ѻý

'Succession Syndrome'; Opioid Use Disorder LAI Approved; Seizures of Ketamine Rising

<ѻý class="mpt-content-deck">— News and commentary from the psychiatry world
MedpageToday
Illustration of a brain shaped maze.

In what is being dubbed "," psychiatrists are warning against the harmful mental health effects of growing up in a powerful, wealthy family. (The Guardian)

There's a new review to help primary care clinicians . "Primary care physicians and pediatricians are well positioned to support the assessment and first-line management of depression in this group, helping patients to regain their health and function," the authors wrote in CMAJ.

In an effort to tackle mental illness, Colorado will now limit the use of body mass index when and limit youth access to diet pills. (AP)

The was helpful for primary care providers to pinpoint patients with substance use disorder. (JAMA Network Open)

The FDA approved the , with weekly and monthly dosing, for moderate-to-severe opioid use disorder, maker Braeburn announced.

Ketamine's increasing popularity as a mental health treatment has been accompanied by a of illegal ketamine by federal, state, and local law enforcement agencies. (JAMA Psychiatry)

In other ketamine news, patients with reported reduced headache intensity with ketamine nasal spray, a retrospective study showed. (Regional Anesthesia & Pain Medicine)

In a review of overnight sleep studies in patients with bipolar affective disorder and recurrent depressive disorder, researchers found significant links between and the two psychiatric conditions. (Scientific Reports)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.